Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
Earnings Data
Report Date
Nov 05, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.06Last Year’s EPS
0.09Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there are positive developments such as growth in the Surgical & Sports Medicine segment, proposed CMS payment reforms, and progress in the ReNu program, the company faced significant challenges with a decline in Advanced Wound Care revenue, overall revenue decrease, and reduced financial guidance.Company Guidance
Surgical & Sports Medicine Revenue Growth
Net product revenue from Surgical & Sports Medicine products for the second quarter was $8.1 million, up 16%.
Proposed CMS Payment Reform
CMS announced a proposed Medicare physician fee schedule expected to bring long-term stabilization to the skin substitute markets and encourage innovation. This is seen as a transformational opportunity for Organogenesis.
ReNu BLA Submission Progress
ReNu program is on track for submission by the end of this year, with all patients completing the second Phase III study. Top line data results expected in September 2025.
Expanded Manufacturing Capacity
Expansion of biomanufacturing capabilities at the new facility in Smithfield, Rhode Island, to support the introduction of new products like Dermagraft and TransCyte.
ORGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ORGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $4.52 | $4.56 | +0.88% |
May 08, 2025 | $5.34 | $3.06 | -42.70% |
Feb 27, 2025 | $3.07 | $6.21 | +102.28% |
Nov 12, 2024 | $3.45 | $4.43 | +28.41% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Organogenesis Holdings Inc (ORGO) report earnings?
Organogenesis Holdings Inc (ORGO) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).
What is Organogenesis Holdings Inc (ORGO) earnings time?
Organogenesis Holdings Inc (ORGO) earnings time is at Nov 05, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ORGO EPS forecast?
ORGO EPS forecast for the fiscal quarter 2025 (Q3) is 0.06.